Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients
April N. Tucker, Katherine A. Tkaczuk, Lynn M. Lewis, Dragana Tomic, Chang K. Lim, Jodi A. Flaws
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Polymorphisms in cytochrome P4503A5 (CYP3A5) may be associated with race and tumor characteristics, but not metabolism and side effects of tamoxifen in breast cancer patients'. Together they form a unique fingerprint.